Principal Investigator
Cynthia Levy
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231102
Clinical Trial Summary
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase
Phase III/IV
Funding Agency/Sponsor
Industry
Disease
PBC (Primary Biliary Cholangitis)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu